
Robert A Zlotecki MD PhD
Gastrointestinal Cancer, Sarcoma, Thoracic Cancer, Urologic Cancer
Clinical Professor Department of Radiation Medicine Medical University of South Carolina
Join to View Full Profile
4033 Highway 17 Bypass, Suite 106Murrells Inlet, SC 29576
Phone+1 843-545-5600
Fax+1 843-545-5660
Dr. Zlotecki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Robert Zlotecki, MD, is a Radiation Oncologist and Clinical Professor with the Medical University of South Carolina, currently based in Murrells Inlet, SC, with sub-specialties in Gastrointestinal Cancer, Sarcoma, Thoracic and Urologic Cancers. He completed his residency in Radiation Oncology at Massachusetts General Hospital/Harvard Medical School in 1993 and his Internship in Internal Medicine at Beaumont Health from 1988-1989. Prior to these, Dr. Zlotecki graduated from the University of Michigan Medical School and earned his PhD in Pharmacology from the same institution. He is experienced in stereotactic body radiotherapy. Dr. Zlotecki has a strong publication history, with papers published in Future Oncology, Practical Radiation Oncology, and other esteemed journals on topics related to radiation's effects and treatment strategies for various cancers.
Education & Training
Massachusetts General HospitalResidency, Radiation Oncology, 1993
Corewell Health East Beaumont (Royal Oak)Internship, Internal Medicine, 1988 - 1989
University of Michigan Medical SchoolClass of 1988
University of MichiganPhD, Pharmacology, 1982 - 1986
Certifications & Licensure
SC State Medical License 2024 - 2027
FL State Medical License 1993 - 2026
MI State Medical License 1988 - 1989
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 4 citationsA phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.Ruchi Singhal, Sherise C Rogers, Ji-Hyun Lee, Brian Ramnaraign, Ilyas Sahin
Future Oncology. 2023-09-01 - 1 citationsAnswering the Call for Radiation Oncologists to Direct Radiopharmaceutical Therapy: Forget the Professional Fee and Get the Hospital to Pay for Support Staff, Infrastr...Robert J Amdur, Vincent Cassidy, Kathryn E Hitchcock, Robert A Zlotecki
Practical Radiation Oncology. 2023-06-16 - 6 citationsReirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma: An Analysis of Treatment Efficacy and Toxicities.Erica L Braschi, Shivam M Kharod, Christopher G. Morris, Andre Spiguel, Charles P. Gibbs
American Journal of Clinical Oncology. 2021-11-10
Press Mentions
UF Health 1st in Southeast to Offer Groundbreaking Imaging DeviceJuly 22nd, 2022
Erratum to: Comparison of Adjuvant Versus Salvage Radiotherapy Policies for Postprostatectomy Radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:329-340August 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









